784168005: Ixazomib citrate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Proteasome inhibitor\Ixazomib citrate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunologic agent (substance)\Ixazomib citrate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Proteasome inhibitor\Ixazomib citrate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Halogen and/or halogen compound\Chlorine and/or chlorine compound\Chlorine compound\Organic chloride compound\Chlorinated hydrocarbon\Dichlorobenzene\Ixazomib citrate
\Halogen and/or halogen compound\Halogenated hydrocarbon\Chlorinated hydrocarbon\Dichlorobenzene\Ixazomib citrate

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Ixazomib citrate

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Ixazomib citrate
\Organic compound\Organic chloride compound\Chlorinated hydrocarbon\Dichlorobenzene\Ixazomib citrate
\Organic compound\Hydrocarbon\Halogenated hydrocarbon\Chlorinated hydrocarbon\Dichlorobenzene\Ixazomib citrate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3761490016 Ixazomib citrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3761491017 Ixazomib citrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5592041000241118 citrate d'ixazomib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ixazomib citrate	Is a	Immunologic agent (substance)	true	Inferred relationship	Some
Ixazomib citrate	Is a	Dichlorobenzene	true	Inferred relationship	Some
Ixazomib citrate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Proteasome inhibitor (disposition)	true	Inferred relationship	Some
Ixazomib citrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Ixazomib (substance)	true	Inferred relationship	Some
Ixazomib citrate	Is a	Proteasome inhibitor	true	Inferred relationship	Some
Ixazomib citrate	Is a	Substance with benzamide structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ixazomib citrate	Inferred relationship	Some	1
Ixazomib (as ixazomib citrate) 3 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ixazomib citrate	Inferred relationship	Some	1
Product containing precisely ixazomib (as ixazomib citrate) 2.3 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ixazomib citrate	Inferred relationship	Some	1

This concept is not in any reference sets